NCT00550771 2017-06-07Phase II Trial to Compare the Safety of Two Chemotherapy Plus Trastuzumab Regimens as Adjuvant Therapy for HER2-positive Breast Cancer (Study P05048)Merck Sharp & Dohme LLCPhase 2 Completed181 enrolled 9 charts